TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has issued an update.
Lee’s Pharmaceutical Holdings Limited has announced a board meeting scheduled for August 26, 2025, to discuss and approve the unaudited interim results for the first half of 2025, and to consider the recommendation of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company is involved in the development, manufacture, and sale of pharmaceutical products, with a focus on the Hong Kong market.
Average Trading Volume: 1,461,215
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.12B
For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.